Christiane Wiegard
Dr. med.
Christiane Wiegard
  • Senior physician
  • Medical Specialist in Internal Medicine and Gastroenterology
Working area

Location

Main Building O10 , Ground Floor, Room number 00.4.108.1
Languages
German (Mother tongue)
English

Areas of expertise

Curriculum vitae

Memberships

Publications

Zurück
  • 2022
  • 2021
  • 2019
  • 2016
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2005
  • 2003
Vor

Transabdominal Ultrasound and Magnetic Resonance Enterography in Inflammatory Bowel Disease: Results of an Observational Retrospective Single-Center Study
Calavrezos L, Bannas P, Warncke M, Wiegard C, Huber S, Manthey C
ULTRASOUND INT OPEN. 2022;8(1):E22-E28.

Contrast-Enhanced Ultrasound Algorithms (CEUS-LIRADS/ESCULAP) for the Noninvasive Diagnosis of Hepatocellular Carcinoma - A Prospective Multicenter DEGUM Study
Schellhaas B, Bernatik T, Bohle W, Borowitzka F, Chang J, Dietrich C, Dirks K, Donoval R, Drube K, Friedrich-Rust M, Gall C, Gittinger F, Gutermann M, Haenle M, von Herbay A, Ho C, Hochdoerffer R, Hoffmann T, Hüttig M, Janson C, Jung E, Jung N, Karlas T, Klinger C, Kornmehl A, Kratzer W, Krug S, Kunze G, Leitlein J, Link A, Lottspeich C, Marano A, Mauch M, Moleda L, Neesse A, Petzold G, Potthoff A, Praktiknjo M, Rösner K, Schanz S, Schultheiß M, Sivanathan V, Stock J, Thomsen T, Vogelpohl J, Vogt C, Wagner S, Wiegard C, Wiesinger I, Will U, Ziesch M, Zimmermann P, Strobel D
ULTRASCHALL MED. 2021;42(2):178-186.

Beurteilung der Leberfibrose
Piecha F, Wiegard C
Gastroenterologie up2date. 2019;2019(15(04): 355-371):.

Attenuated viral hepatitis in Trem1-/- mice is associated with reduced inflammatory activity of neutrophils
Kozik J, Trautmann T, Carambia A, Preti M, Lütgehetmann M, Krech T, Wiegard C, Heeren J, Herkel J
SCI REP-UK. 2016;6:28556.

Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy
Than N, Wiegard C, Weiler-Normann C, Füssel K, Mann J, Hodson J, Hirschfield G, Lohse A, Adams D, Schramm C, Oo Y
SCAND J GASTROENTERO. 2016;51(3):329-336.

Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis
Schramm C, Wahl I, Weiler-Normann C, Voigt K, Wiegard C, Glaubke C, Brähler E, Löwe B, Lohse A, Rose M
J HEPATOL. 2014;60(3):618-624.

Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms
Sebode M, Peiseler M, Franke B, Schwinge D, Schoknecht T, Wortmann F, Quaas A, Petersen B, Ellinghaus E, Baron U, Olek S, Wiegard C, Weiler-Normann C, Lohse A, Herkel J, Schramm C
J HEPATOL. 2014;60(5):1010-6.

CD4+ T-cell help is required for effective CD8+ T cell-mediated resolution of acute viral hepatitis in mice
Trautmann T, Kozik J, Carambia A, Richter K, Lischke T, Schwinge D, Mittrücker H, Lohse A, Oxenius A, Wiegard C, Herkel J
PLOS ONE. 2014;9(1):e86348.

Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis.
Weiler-Normann C, Schramm C, Quaas A, Wiegard C, Glaubke C, Pannicke N, Hübener S, Lohse A
J HEPATOL. 2013;58(3):529-534.

FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency
Peiseler M, Sebode M, Franke B, Wortmann F, Schwinge D, Quaas A, Baron U, Olek S, Wiegard C, Lohse A, Weiler-Normann C, Schramm C, Herkel J
J HEPATOL. 2012;57(1):125-132.

Autoimmunerkrankungen mit Leberbeteiligung
Sebode M, Wiegard C, Lohse A
Gastroenterologie up2date. 2012;08(02):129-141.

Diagnostic criteria for autoimmune hepatitis.
Lohse A, Wiegard C
BEST PRACT RES CL GA. 2011;25(6):665-671.

Treatment response in patients with autoimmune hepatitis.
Schramm C, Weiler-Normann C, Wiegard C, Hellweg S, Müller S, Lohse A
HEPATOLOGY. 2010;52(6):2247-2248.

A case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-alpha blockade.
Weiler-Normann C, Wiegard C, Schramm C, Lohse A
AM J GASTROENTEROL. 2009;104(11):2877-2878.

Scoring systems for the diagnosis of autoimmune hepatitis: past, present, and future.
Wiegard C, Schramm C, Lohse A
SEMIN LIVER DIS. 2009;29(3):254-261.

Mycophenolate mofetil as second line therapy in autoimmune hepatitis?
Hennes E, Oo Y, Schramm C, Denzer U, Buggisch P, Wiegard C, Kanzler S, Schuchmann M, Boecher W, Galle P, Adams D, Lohse A
AM J GASTROENTEROL. 2008;103(12):3063-3070.

Defective T helper response of hepatocyte-stimulated CD4 T cells impairs antiviral CD8 response and viral clearance.
Wiegard C, Wolint P, Frenzel C, Cheruti U, Schmitt E, Oxenius A, Lohse A, Herkel J
GASTROENTEROLOGY. 2007;133(6):2010-2018.

Murine liver antigen presenting cells control suppressor activity of CD4+CD25+ regulatory T cells
Wiegard C, Frenzel C, Herkel J, Kallen K, Schmitt E, Lohse A
HEPATOLOGY. 2005;42(1):193-199.

MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes
Herkel J, Jagemann B, Wiegard C, Lazaro J, Lueth S, Kanzler S, Blessing M, Schmitt E, Lohse A
HEPATOLOGY. 2003;37(5):1079-1085.

Letzte Aktualisierung aus dem FIS: 28.11.2024 - 03:39 Uhr